GB0822170D0 - Telmisartan with diuretic formulations - Google Patents

Telmisartan with diuretic formulations

Info

Publication number
GB0822170D0
GB0822170D0 GBGB0822170.7A GB0822170A GB0822170D0 GB 0822170 D0 GB0822170 D0 GB 0822170D0 GB 0822170 A GB0822170 A GB 0822170A GB 0822170 D0 GB0822170 D0 GB 0822170D0
Authority
GB
United Kingdom
Prior art keywords
telmisartan
diuretic
formulations
diuretic formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0822170.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arrow International Ltd
Original Assignee
Arrow International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arrow International Ltd filed Critical Arrow International Ltd
Priority to GBGB0822170.7A priority Critical patent/GB0822170D0/en
Publication of GB0822170D0 publication Critical patent/GB0822170D0/en
Priority to GBGB0913884.3A priority patent/GB0913884D0/en
Priority to PCT/GB2009/002791 priority patent/WO2010063995A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0822170.7A 2008-12-04 2008-12-04 Telmisartan with diuretic formulations Ceased GB0822170D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0822170.7A GB0822170D0 (en) 2008-12-04 2008-12-04 Telmisartan with diuretic formulations
GBGB0913884.3A GB0913884D0 (en) 2008-12-04 2009-08-10 Telmisartan with diuretic formulations
PCT/GB2009/002791 WO2010063995A2 (en) 2008-12-04 2009-12-01 Telmisartan with diuretic formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0822170.7A GB0822170D0 (en) 2008-12-04 2008-12-04 Telmisartan with diuretic formulations

Publications (1)

Publication Number Publication Date
GB0822170D0 true GB0822170D0 (en) 2009-01-14

Family

ID=40289506

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0822170.7A Ceased GB0822170D0 (en) 2008-12-04 2008-12-04 Telmisartan with diuretic formulations
GBGB0913884.3A Ceased GB0913884D0 (en) 2008-12-04 2009-08-10 Telmisartan with diuretic formulations

Family Applications After (1)

Application Number Title Priority Date Filing Date
GBGB0913884.3A Ceased GB0913884D0 (en) 2008-12-04 2009-08-10 Telmisartan with diuretic formulations

Country Status (2)

Country Link
GB (2) GB0822170D0 (en)
WO (1) WO2010063995A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2612658A1 (en) * 2012-01-05 2013-07-10 Laboratorios Lesvi, S.L. Pharmaceutical compositions of 4'-[(1,4'dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid and is 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070097511A (en) * 2004-12-17 2007-10-04 베링거 인겔하임 인터내셔날 게엠베하 Combination therapy comprising telmisartan and hydrochlorothiazide
CA2836545C (en) * 2006-06-16 2016-08-09 Lek Pharmaceuticals D.D. Pharmaceutical composition comprising telmisartan and hydrochlorothiazide
CN101134032A (en) * 2007-09-24 2008-03-05 湖北丝宝药业有限公司 Compound preparations for treating hypertension and method for preparing the same
EP2203158A4 (en) * 2007-10-30 2012-12-26 Reddys Lab Ltd Dr Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide

Also Published As

Publication number Publication date
WO2010063995A3 (en) 2010-11-25
GB0913884D0 (en) 2009-09-16
WO2010063995A2 (en) 2010-06-10

Similar Documents

Publication Publication Date Title
TWI370466B (en) Trensformer structure
EP2328207A4 (en) Battery
IL209268A0 (en) Connecting structure
PL2918172T3 (en) Połączenia środków kontroli biologicznej i fungicydów
AP3047A (en) Turbine arrangement
GB2459423B (en) Spar structures
ZA201103778B (en) Photovoltaic devices including heterojunctions
IL209733A0 (en) New benzimidazole derivatives
EP2273603A4 (en) Pigment-sensitized solar battery
GB0822633D0 (en) Formulation
GB2462054A8 (en) Biodiesel
GB0800788D0 (en) Niovel formulation
HK1156209A1 (en) Stable benzimidazole formulation
GB0718490D0 (en) Biodiesel
GB2463076B (en) Articulated chairs
GB0814376D0 (en) Formulation
GB0913884D0 (en) Telmisartan with diuretic formulations
ZA201104435B (en) Solar geyers
GB2456343B (en) Fuelling
HK1146333A1 (en) Battery
IL208925A0 (en) Stable benzimidazole formulation
GB0815621D0 (en) In-roof solar
GB0814520D0 (en) Solar optomizer
GB0817663D0 (en) Formulation
GB0806445D0 (en) Formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)